Get started
Author

Reina Hibbert

Phase I: Veliparib with cisplatin (CP) and vinorelbine (VNR) in advanced triple-negative breast cancer (TNBC) and/or BRCA mutation-associated breast cancer.
2014 · Eve T. Rodler, Julie Gralow, et al. · Journal of Clinical Oncology · 15
ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372.
2018 · Shailender Bhatia, Andrew Scott Brohl, et al. · Journal of Clinical Oncology · 12
ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in patients with Merkel cell carcinoma and lymph node metastases.
2026 · Shailender Bhatia, Ted Gooley, et al. · Journal of Clinical Oncology · 5
Phase II trial of the CDK4/6 inhibitor abemaciclib in patients (pts) with advanced and refractory well‐differentiated gastroenteropancreatic neuroendocrine tumors (GEP NETs).
2021 · Kit Man Wong, Bojana Irene Askovich, et al. · Journal of Clinical Oncology · 3
ADAM Trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in Merkel cell carcinoma patients with lymph node metastases; NCT03271372
2022 · Wenwen Chen, Shailender Bhatia, et al. · Journal of Investigative Dermatology · 2
Phase I/IB multicenter study of afatinib in combination with capecitabine in patients (pts) with refractory solid tumors and pancreatico-biliary cancers.
2017 · Amy E. Chang, Safi Shahda, et al. · Journal of Clinical Oncology · 2
Phase I/Ib study of afatinib with capecitabine in patients with refractory solid tumors and pancreaticobiliary cancers.
2025 · Gentry Teng King, Kelsey K. Baker, et al. · Journal of Clinical Oncology · 1
PDF
Abstract CT044: A phase 1B investigator-initiated trial of niraparib lead-in, followed by niraparib plus dostarlimab for metastatic BRCA1/2-mutated breast, tubo-ovarian, and pancreatic cancers
2026 · Elizabeth M. Swisher, Andrew Coveler, et al. · Cancer Research
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers
2025 · Gentry G. King, Kelsey K. Baker, et al. · Cancers
PDF
Works count: 9
Citation count: 40
H-index: 3
I10-index: 2
Year
Topic
Type